BSP Work Programme
Reference Standards from the BSP programme adopted in 2024
Plasma-Derived Products
- Human anti-D immunoglobulin BRP batch 2
Biotechnology Products
- Heparin low-molecular-mass for calibration CRS batch 6
- Golimumab BRP batch 1
Current projects
Vaccines for Human and Veterinary Use
- Validation of a rabies in vitro potency assay (reporting phase)
- Establishment of a Clostridia (multi-component) rabbit antiserum (for vaccines-vet. use) BRP
- Establishment of a Diphtheria toxin BRP replacement batch
- Establishment of BRR for non-endotoxin pyrogens in MAT
Plasma-Derived Products
- Establishment of a Human coagulation Factor IX concentrate BRP replacement batch (testing phase completed)
- Establishment of Immunoglobulin for anti-A, anti-B antibodies test BRP replacement batches (testing phase completed)
- Establishment of a Human coagulation Factor VIII concentrate BRP replacement batch
- Establishment of Human Albumin for electrophoresis BRP replacement batches
Biotechnology Products
- Evaluation of an in vitro assay for Erythropoietin
- Establishment of recombinant major allergen rBet v 1 and rPhl p 5a CRS replacement batches (reporting phase)
- Establishment of an Erythropoietin CRS for glycan analysis, peptide mapping and SDS-PAGE/Immunoblotting
- Establishment of a Somatropin CRS replacement batch
- Establishment of a Heparin Sodium BRP replacement batch
Projects foreseen for 2025 and beyond
Vaccines for Human and Veterinary Use
- Validation of an in vitro assay for Tetanus/ Diphtheria vaccines
- Establishment of a Diphtheria Vaccine BRP replacement batch
Plasma-Derived Products
- Establishment of a Human anti-D immunoglobulin BRP replacement batch
- Establishment of Prekallikrein activator in albumin BRP replacement batches
Biotechnology Products
- Glatiramer method evaluation and establishment of a BRP
- Establishment of an Endotoxin BRP replacement batch
- Establishment of a Heparin Low-Molecular-Mass for calibration CRS replacement batch
- Establishment of an Erythropoietin BRP replacement batch
- Establishment of an Erythropoietin for SEC system suitability CRS replacement batch
- Establishment of a Ustekinumab BRP
- Establishment of a Heparin Low-Molecular-Mass for assay BRP replacement batch
- Establishment of Prekallikrein activator in albumin BRP replacement batches
Recent Pharmeuropa Bio & Scientific Notes articles
The final study reports of BSP projects are published in Pharmeuropa Bio & Scientific Notes accessible free of charge from the Pharmeuropa website
Recent publications include:
- Collaborative Study for the Calibration of the Ph. Eur. Prekallikrein Activator in Albumin Biological Reference Preparation batches 8, 9 and 10
- Collaborative study for the establishment of Golimumab Biological Reference Preparation Batch 1
- Establishment of hepatitis A virus coating reagent batch 2 for in vitro potency assay of hepatitis A vaccines by ELISA
- Establishment of Erythropoietin for physicochemical tests CRS batch 2
- Study for the Establishment of the Ph. Eur. Human Anti-D immunoglobulin Biological Reference Preparation batch 2
Search
Search for availability, price, batch validity statements (BVS), leaflets, safety data sheets (SDS), a list of newly adopted reference standards, batch release dates...
Place an order
Combistats TM
CombiStats is a computer program for the statistical analysis of data from biological dilution assays or potency assays. The software was developed at the EDQM and can perform calculations according to Chapter 5.3 of the European Pharmacopoeia.
More information